Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women
Alice Stek(University of Southern California), Mark Mirochnick(Boston University), Sandra Burchett(Harvard University), Edmund V. Capparelli(University of California San Diego), Elizabeth Smith(National Jewish Health), David E. Shapiro(Intercept Pharmaceuticals (United States)), Kittipong Rungruengthanakit(Chiang Mai University), Brookie M. Best, Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Jiajia Wang(Capital Medical University), Régis Kreitchmann(Irmandade da Santa Casa de Misericórdia de São Paulo), Tim R. Cressey
Cited by 48
Related Papers
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
|The Lancet|2022|15.8k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k